Fulcrum Therapeutics Inc (FULC) — Financial Flexibility Index
Fulcrum Therapeutics Inc (FULC) has a Financial Flexibility Index of -0.85x as of September 2025. Free cash flow of $-14.10 Million (operating CF $-14.19 Million minus capex $90.00K) represents -1% of total liabilities ($16.49 Million). Check FULC strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Fulcrum Therapeutics Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Fulcrum Therapeutics Inc across 8 annual periods. See Fulcrum Therapeutics Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Fulcrum Therapeutics Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Fulcrum Therapeutics Inc. For the full company profile including market capitalisation, see Fulcrum Therapeutics Inc (FULC) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.11x | $-1.94 Million | $-2.22 Million | $17.68 Million | ▲ +97.3% |
| 2023 | -4.02x | $-90.46 Million | $-90.97 Million | $22.50 Million | ▼ -17.3% |
| 2022 | -3.43x | $-95.09 Million | $-97.05 Million | $27.74 Million | ▼ -4.7% |
| 2021 | -3.27x | $-76.77 Million | $-78.48 Million | $23.46 Million | ▼ -115.1% |
| 2020 | -1.52x | $-52.31 Million | $-53.66 Million | $34.40 Million | ▲ +8.3% |
| 2019 | -1.66x | $-38.63 Million | $-39.48 Million | $23.29 Million | ▼ -19.4% |
| 2018 | -1.39x | $-13.58 Million | $-22.56 Million | $9.77 Million | ▲ +76.9% |
| 2017 | -6.02x | $-18.17 Million | $-20.07 Million | $3.02 Million | — |